Colorectal Cancer

1. Globally leading low-position anal sphincter preservation technique; mature comprehensive treatment for late-stage metastasis.

In Europe and America, colorectal cancer surgery is mostly focused on radical resection, which often results in anal resection and lifelong stoma. Top hospitals in China specialize in ultra-low anterior resection of rectal cancer with sphincter preservation, which preserves the patient's normal bowel function to the greatest extent possible while completely removing the tumor, thus greatly improving the patient's quality of life after surgery.

2. MDT (Multidisciplinary Team) integrated diagnosis and treatment plan is mature.

For colorectal cancer with liver and lung metastases, relapses, and refractory cases, China has a mature multidisciplinary team (MDT) approach with high success rates in palliative and conversion therapy.

3. Overall costs are significantly lower than in Europe and America, with no hidden fees.

China has widely adopted proton and heavy ion therapy and robotic minimally invasive surgery with no hidden fees, significantly reducing the cost of treating serious illnesses . Under the same conditions, the overall cost is usually only one-third of that in Europe and the United States, or even lower.

4. Zero waiting period, rapid medical intervention to avoid delays in treatment.

In Europe, America, Japan, and South Korea, the waiting time for specialist appointments and surgeries at public hospitals is generally 3-12 months, while private institutions are extremely expensive and still have a waiting period of 1-3 months. China has a well-established international medical channel, and colorectal  cancer patients who come to China for medical tourism through Trisana Medguide can have an in-person consultation within 3 days and start treatment within 7 days, allowing for early admission and early recovery and preventing delays in treatment .

1. Connect with China's top medical resources to accurately and personalizedly match hospitals and specialists.

We connect you directly with China's top 10 tertiary hospitals and academician-level experts, providing you with accurate expert appointments, surgery schedule bookings, and personalized treatment plans, eliminating detours in your medical journey.

2. Rigorous and traceable service processes ensure precise and efficient medical tourism.

From initial consultation and assessment, visa assistance, and itinerary planning, to in-hospital medical coordination, postoperative rehabilitation management, and long-tail services after returning home, every step is managed with standard operating procedures (SOPs).

3. Assemble an elite service team to provide butler-style, one-on-one care throughout the entire process.

Our team comprises six elite professionals with advanced degrees, including medical masters and doctors, specializing in medical consultation, medical translation, visa assistance, health management, information development, and professional care. We offer customized service plans and provide one-on-one concierge-style care throughout the entire process.

4. Integrated medical tourism one-stop fully managed VIP service

We offer full-service concierge services, including private car service, hotel and apartment booking, medical services such as medical escort and translation, and access to expedited medical care, as well as daily care such as housekeeping and customized meals, making patients and their families feel at home and worry-free throughout the entire process.

0.Why are Fudan University Cancer Hospital, Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, Xinhua Hospital affiliated with Shanghai Jiao Tong University School of Medicine recommended as the best choice?

Fudan University Cancer Hospital:

Comprehensive treatment of digestive tract tumors is its core strength. Treatment plans for colorectal and gastric cancer are often included in national guidelines, and the overall survival of patients is comparable to top European and American cancer centers. The Department of Colorectal Surgery (Cai Sanjun/Xu Ye team) is a top-tier domestic team for colon cancer and ranks first in Shanghai for surgical volume: over 7,000 colorectal cancer surgeries performed in 2024, with a 5-year overall survival rate of 73.87% (Stage I 91.9%, Stage II 87.2%, Stage III 70.5%), with 87% of first-time surgeries for Shanghai residents, benchmarked against Western standards. Technology: Laparoscopic/Da Vinci robotic CME complete mesocolic excision is routine. Features include treatment for liver and lung peritoneal metastases, hereditary intestinal cancer, and neoadjuvant therapy for locally advanced disease (short-course radiotherapy + chemotherapy/immunotherapy TORCH regimen cCR > 50%). MDT: Formalized since 2005, with integrated collaboration between surgery, medical oncology, radiation oncology, pathology, and imaging. International Patients: Dual campuses in Xuhui/Pudong, International Department offers English medical records and pre-approval for commercial insurance. Preferred choice for foreign patients with complex metastases or requiring sphincter preservation.

Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine:

A national benchmark for comprehensive diagnosis and treatment of digestive tract tumors. It has established systems for early cancer endoscopy, neoadjuvant therapy for locally advanced disease, minimally invasive robotic surgery, and stratified palliative care for advanced disease. The 5-year survival rates for gastric and colorectal cancer have reached internationally advanced levels. It possesses Shanghai's first domestically developed proton therapy system, enabling precise targeting of gastrointestinal tumors with minimal damage. An integrated closed-loop system for the diagnosis and treatment of digestive tract tumors has been established, and it leads the formulation of national guidelines. (Zheng Minhua/Lu Aiguo/Feng Bo) The team performs over a thousand colorectal surgeries annually, with a minimally invasive rate of over 82%. Da Vinci Xi + 3D fluorescence laparoscopy are fully equipped.

Technology: 5-year overall survival for D3 radical resection of right-sided colon cancer is 70.37% (long-term follow-up of 177 cases); sphincter preservation for ultra-low rectal cancer with taE-ISR/TaTME is mature, with neoadjuvant chemoradiotherapy + sphincter preservation as a signature treatment. Synchronous resection of primary and metastatic lesions for colorectal liver metastases, and robotic surgery + hyperthermic intraperitoneal chemotherapy for recurrent cancer have unique advantages. MDT: Regular multidisciplinary meetings for gastrointestinal tumors have been held since 2005.

It provides the strongest support for elderly patients with combined diabetes/cardiovascular and cerebrovascular diseases. International Patients: Building 10, International Department, 96 beds, 16 languages, direct billing for BUPA/Allianz. Evaluation takes 2-5 days. Suitable for elderly patients with comorbidities, those seeking sphincter preservation, and overseas patients with commercial insurance. While the pure oncology volume is slightly lower than Fudan Cancer Hospital, the surgical and comprehensive internal medicine support is balanced.

Xinhua Hospital affiliated with Shanghai Jiao Tong University School of Medicine:

Colorectal/colon cancer is in Shanghai's top-tier Class III hospitals, offering excellent value for money. The Department of Colorectal and Anal Surgery has 61 beds and performs approximately 3,000 surgeries annually. It features dual robotic platforms (Da Vinci Xi + domestic Toumai) and is designated as a Minimally Invasive Robotic Clinical Demonstration Center.

Technological Features: ISR for ultra-low rectal cancer, taTME, and everted sphincter preservation are signature techniques. Over a hundred robotic sphincter-preserving surgeries have been performed, with significantly higher sphincter preservation rates for mid-to-low rectal cancer compared to traditional open surgery.

It also covers IBD surgery for Crohn's disease/ulcerative colitis and leads the Shanghai Jiao Tong University Colorectal Cancer Diagnosis and Treatment Center. Data: 5-year survival for colorectal cancer is approximately 68% (Western level), with a low postoperative complication rate. MDT: Fixed joint outpatient clinics involving gastrointestinal surgery, medical oncology, radiation oncology, and pathology. The pathway from neoadjuvant chemoradiotherapy to surgery to adjuvant therapy is clear.

m0:Some representatives of medical experts in colorectal cancer:

m1:

doctor:

m2:

doctor:

m3:

doctor:

case:96823148470861826